3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
3
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Burkitt Lymphoma
2
Preleukemia
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoproliferative Disorders
1
Lymphoma, Primary Effusion
1
Lymphatic Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Mast-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Hematologic Neoplasms
1
Hematologic Diseases
1
GATA2 Deficiency
1
Bone Marrow Diseases
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
venetoclax
7
ibrutinib
7
Rituximab
6
Mycophenolic Acid
5
Cyclophosphamide
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Sirolimus
4
zanubrutinib
3
pirtobrutinib
3
Peripheral Blood Stem Cell Transplantation
3
Dexamethasone
3
Cyclosporine
3
carfilzomib
2
acalabrutinib
2
Tacrolimus
2
Melphalan
2
Cyclosporins
2
Calcium Dobesilate
2
Busulfan
2
Bendamustine Hydrochloride
2
talquetamab
1
pembrolizumab
1
loncastuximab tesirine
1
ixazomib
1
fludarabine
1
Transplantation
1
Specimen Handling
1
Rifaximin
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Bone Marrow Transplantation
×
90 days
×
Clear all
No trials found.